The U.S. bioanalytical testing services market size is anticipated to reach USD 3.39 billion by 2030 and is expected to expand at a CAGR of 9.33% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by a surge in drug development and the increasing complexity of therapeutic modalities. As pharmaceutical and biopharmaceutical companies race to...